Paragon Sports Medicine

Home/ Peptides/ Pinealon

BAck to all peptides

Pinealon

Pinealon is a bioactive peptide derived from pineal gland tissue that functions as a circadian rhythm regulator and neuroprotective agent. It is a short tripeptide (Glu-Asp-Arg, C15H26N6O8) studied for its effects on neuronal and pineal tissue. Originally developed from pineal gland extracts, Pinealon represents a targeted approach to addressing age-related decline in circadian rhythm regulation and cognitive function.

This peptide has gained considerable attention in neurology and age-related medicine for its studied role in cognitive enhancement, sleep optimization, and neuroprotection in both preclinical and clinical studies. Pinealon exhibits unique selectivity for pineal gland tissue and maintains bioactivity across various physiological conditions, making it distinctive among neurologically active peptides.

Logo of Pinealon featuring stylized pine tree branches and bold text spelling Pinealon.

Overview

Pinealon demonstrates high water solubility and selective uptake by pineal gland tissue, contributing to its targeted therapeutic profile. The peptide is metabolized through tissue-specific pathways and maintains extended bioactivity through regulatory feedback mechanisms with the pineal gland.

Patient consulting with Dr. Ched Garten at Paragon, symbolizing advanced non-surgical care for joint, tendon, muscle, and pain issues.

Chemical structure & Properties

  • Molecular Formula: C15H26N6O8
  • Molecular Weight: ~418.4 Da
  • Sequence: Glu-Asp-Arg (EDR), a defined tripeptide
  • Half-life: Extended through pineal tissue interaction
  • Stability: Stable under physiological conditions with selective pineal affinity

Mechanism of Action

Pinealon has been studied for effects on several interconnected molecular pathways:

Circadian Rhythm Regulation

Proposed mechanisms, none demonstrated in humans, include:

  • A melatonin-restoring or circadian-synchronising effect has not been formally demonstrated in humans.
  • Improvement of natural sleep-wake cycle synchronization
  • Enhancement of circadian rhythm entrainment mechanisms
  • Optimization of light-dark cycle responsiveness

Neuroprotective Mechanisms

The peptide provides comprehensive neuroprotection through:

  • Enhanced antioxidant enzyme activity and oxidative stress reduction
  • Improved neuronal membrane stability and cellular integrity
  • Protection against neurotoxic substances and age-related damage
  • Promotion of neuronal survival pathways and synaptic maintenance

Neurotransmitter System Optimization

Pinealon influences neurotransmitter function by:

  • Enhancing serotonin synthesis and receptor sensitivity
  • Optimizing dopamine pathway activity and regulation
  • Balancing GABA-ergic inhibitory neurotransmission
  • Supporting acetylcholine production for cognitive function

Neuroendocrine Regulation

The peptide modulates neuroendocrine function through:

  • Hypothalamic-pituitary-adrenal (HPA) axis optimization
  • Growth hormone release regulation and enhancement
  • Cortisol response modulation and stress resilience
  • Overall hormonal homeostasis restoration

Areas Investigated in

the Research Literature

Patient consulting with Dr. Ched Garten at Paragon, symbolizing advanced non-surgical care for joint, tendon, muscle, and pain issues.

Current Clinical Evidence

Safety Profile and Considerations

Clinical Safety Data

No controlled human safety trial has been located. Reported experience describes:

  • Excellent tolerability with minimal adverse effects
  • No serious adverse events described in the available reports
  • Well-tolerated across diverse age groups and health conditions
  • Suitable for long-term use with appropriate cycling protocols

Reported Side Effects

Mild and Transient Effects:

  • Occasional vivid dreams or altered sleep patterns during initiation
  • Rare injection site reactions (mild erythema, temporary swelling)
  • Transient mood changes during treatment adjustment period
  • Enhanced dream recall or unusual sleep experiences (uncommon)

Potential Concerns

Sleep Pattern Alterations:

  • Initial adjustment period may involve sleep architecture changes
  • Individual sensitivity to circadian rhythm modifications
  • Timing of administration critical for optimal therapeutic response

Individual Variability:

  • Dosing has not been standardized across studies
  • Different response patterns based on baseline circadian rhythm health
  • Potential for heightened awareness or altered perception in sensitive individuals

Contraindications

Pinealon should be avoided in:

  • Active psychotic disorders or severe psychiatric instability
  • Pregnancy and breastfeeding (insufficient safety data available)
  • Severe sleep disorders requiring intensive medical management
  • Known hypersensitivity to peptide compounds or components

Regulatory Status and Legal Considerations

Regulatory information current as of 28 August 2026. This is a summary, not legal or medical advice, and status can change.

FDA Status

  • Classification: Research peptide/investigational compound
  • Approval Status: Not approved for human therapeutic use in the United States
  • Compounding: Available through specialized compounding pharmacies
  • Research Use: Permitted in clinical research settings with appropriate oversight

International Status

  • European Medicines Agency: Not approved for therapeutic use
  • Other Jurisdictions: Regulatory status varies by country
  • Research Applications: Widely used in international research protocols

Legal Availability

  • Commercial Status: Not FDA approved. Not part of the current compounding lists.
  • Quality Control: Variable quality and purity standards across suppliers
  • Clinical Use: Limited to research settings and specialized medical practices
  • Patient Access: Requires healthcare provider supervision and prescription
Man seated indoors with a soccer ball in natural light, representing Paragon’s musculoskeletal recovery expertise and regenerative treatment focus.

Conclusion

What the evidence supports

Pinealon is a short peptide studied mainly in animal models, with some Russian clinical literature, for effects on cognition, circadian regulation and neuroprotection. The independent evidence base is limited, human trials are small, and there is no standardized dosing or long-term safety data. Pinealon is not FDA approved for any therapeutic use in the United States. This page summarizes the published research and nothing further.

Pinealon SCIENTIFIC

DATA SUMMARY

MOLECULAR CHARACTERISTICS
RESEARCH APPLICATIONS SUMMARY
CLINICAL EVIDENCE SUMMARY
SAFETY PROFILE
REGULATORY STATUS
Parameter
Molecular Weight
Amino Acid Length
Half-Life
Bioavailability
Detection Window
Value
approx. 418.4 Da
3 residues (Glu-Asp-Arg)
Extended (pineal interaction)
High with selective pineal uptake
Up to 7 days (tissue-specific)
Application
Cognitive Enhancement
Circadian Regulation
Neuroprotection
Neuroendocrine Function
Reported outcome (model)
Memory and attention improvement reported in animal models
Reported sleep quality improvement
Reduced neurodegeneration markers in animal models
Increased GH and reduced cortisol in animal models
Study Type
Cognitive Trial
Neuroendocrine Study
Sleep Quality Study
Population
60 healthy adults
45 adults
35 adults
Results
Cognitive improvement reported
Hormonal optimization
Significant sleep improvement
Limitations
Single geographic region
Relatively small sample size
Single-center study
Parameter
Acute Toxicity
Organ Toxicity
Adverse Events
Long-term Safety
Finding
No toxicity reported (up to 10 mg tested)
No adverse changes in major organs
Minimal: vivid dreams, mild injection reactions
No extended-duration safety data
Authority
FDA
WADA Status
DEA
Classification
Research Peptide
Non-approved substance
Unscheduled
Status
Not approved for therapeutic use
Prohibited at all times under S0
Not controlled substance

About this library

This library is published for education. It summarizes published research on compounds studied in this field. Many have no approved medical use, and several cannot lawfully be compounded in the United States. The presence of a page here does not mean Paragon offers that compound. Nothing on these pages is an offer to treat.

This page is general education about a compound studied in this field. Nothing here is medical advice, a recommendation, or an offer to prescribe or supply. A page appearing in this library does not mean Paragon Sports Medicine offers that compound.

Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. Pinealon is not approved by the FDA for human therapeutic use. Patients should consult with qualified healthcare providers before considering any peptide therapy.

Statements on this page have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Many peptides described here are not FDA approved for the uses discussed, and some cannot lawfully be compounded in the United States. Nothing on this page is medical advice or a recommendation for any individual. Whether any therapy is appropriate depends on your history, your laboratory results, and a clinical evaluation. Individual results vary. This page is published for education. Use of this site does not create a physician-patient relationship.

References

01
Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation Res. 2011.
02
Pinealon protects the rat offspring from prenatal hyperhomocysteinemia. Int J Clin Exp Med. 2012.
03
Role of Mono- and Divalent Ions in Peptide Glu-Asp-Arg-DNA Interaction. J Phys Chem B. 2019.
04
Effect of synthetic peptides on aging of patients with chronic polymorbidity and organic brain syndrome of the central nervous system in remission. Adv Gerontol. 2015.